New patent for Axsome drug AUVELITY

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for AUVELITY
Annual Drug Patent Expirations for AUVELITY

Auvelity is a drug marketed by Axsome and is included in one NDA. There are ninety-three patents protecting this drug.

This drug has one hundred and twenty-two patent family members in thirty countries.

The generic ingredient in AUVELITY is bupropion hydrochloride; dextromethorphan hydrobromide. Additional details are available on the bupropion hydrochloride; dextromethorphan hydrobromide profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top